News
Shares of USA-based NextCure slumped 26% to $0.50 on Monday, after the company announced a strategic partnership with ...
Cambridge, UK-based Maxion Therapeutics today announced the appointment of Dr Stefan Härtle as chief development officer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback